A Canadian Clinical Practice Algorithm for the Management of Patients with Non-Variceal Upper Gastrointestinal Bleeding
Authors:
- Alan BarkunABAlan Barkun
- for the Nonvariceal Upper GI Bleeding Consensus Conference GroupFGfor the Nonvariceal Upper GI Bleeding Consensus Conference Group
Open Access
- 1 January 2004
- journal article
- research article
- Published by Wiley in Canadian Journal of Gastroenterology and Hepatology
- Vol. 18 (10) , 605-609
Abstract
AIM:To use current evidence-based recommendations to provide a user-friendly clinical algorithm for the management of upper gastrointestinal bleeding, adapted to the Canadian environment.METHODS:A multidisciplinary consensus group of 25 participants representing 11 national societies used a seven-step approach to develop recommendations according to accepted standards. Sources of data included narrative and systematic reviews as well as published and new meta-analyses. A small writing subgroup subsequently created the algorithm.RESULTS:Recommendations emphasize appropriate initial resuscitation of the patient and a multidisciplinary approach to clinical risk stratification that determines the need for early endoscopy. Early endoscopy allows safe and prompt discharge of selected patients classified as low risk. Endoscopic hemostasis is reserved for patients with high-risk endoscopic lesions. Although monotherapy with injection or thermal coagulation is effective, the combination is superior to either treatment alone. High-dose intravenous proton-pump inhibition is recommended in patients who have undergone successful endoscopic therapy. Routine second-look endoscopy is not recommended. Patients with upper gastrointestinal bleeding secondary to ulcer disease should be tested and treated forHelicobacter pyloriinfection.CONCLUSIONS:This algorithm should facilitate appropriate risk stratification, use of endoscopic therapy and the appropriate utilization of proton-pump inhibition to optimize the care of patients with upper gastrointestinal bleeding. The algorithm should be customized to the resources of individual medical centres. Its application should be studied with appropriate outcomes recorded and validation performed.Keywords
Funding Information
- Canadian Association of Gastroenterology
- Altana Pharma Canada Inc
- AstraZeneca Canada
- Carsen Group Inc
- Canadian Institutes of Health Research
- McGill University
This publication has 38 references indexed in Scilit:
- Nasogastric aspirate predicts high-risk endoscopic lesions in patients with acute upper-GI bleedingGastrointestinal Endoscopy, 2004
- Newer endoscopic therapies decrease both re-bleeding and mortality in high-risk patients with acute peptic ulcer bleeding: A series of meta-analysesGastroenterology, 2003
- High dose intravenous proton pump inhibition decrease both re-bleeding and mortality in high-risk patients with acute peptic ulcer bleeding: A series of meta-analysesGastroenterology, 2003
- Omeprazole as adjuvant therapy to endoscopic combination injection sclerotherapy for treating bleeding peptic ulcerThe American Journal of Medicine, 2001
- Endoscopy for Acute Nonvariceal Upper Gastrointestinal Tract Hemorrhage: Is Sooner Better?Archives of internal medicine (1960), 2001
- A Prospective Randomized Comparative Trial Showing That Omeprazole Prevents Rebleeding in Patients With Bleeding Peptic Ulcer After Successful Endoscopic TherapyArchives of internal medicine (1960), 1998
- Prospective Evaluation of a Clinical Guideline Recommending Hospital Length of Stay in Upper Gastrointestinal Tract HemorrhageJAMA, 1997
- Cure with omeprazole plus amoxicillin versus long-term ranitidine therapy in Helicobacter pylori–associated peptic ulcer bleedingGastrointestinal Endoscopy, 1997
- Combination therapy using adrenaline and heater probe to reduce rebleeding in patients with peptic ulcer haemorrhage: A prospective randomized trialBritish Journal of Surgery, 1995
- Prognostic factors in upper gastrointestinal bleedingDigestive Diseases and Sciences, 1994